| Reference |
|---|
Uehara N, Shibusawa N, Mikami Y, Kyumoto Nakamura Y, Sonoda S, Kato H, et al. Bone metastatic mammary tumor cell-derived extracellular vesicles inhibit osteoblast maturation via JNK signaling. Arch Biochem Biophys. 2023;750:109821 pubmed publisher |
Miyagawa K, Tenshin H, Mulcrone P, Delgado Calle J, Subler M, Windle J, et al. Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation. JCI Insight. 2023;8: pubmed publisher |
Gao X, Sun X, Cheng H, Ruzbarsky J, Mullen M, Huard M, et al. MRL/MpJ Mice Resist to Age-Related and Long-Term Ovariectomy-Induced Bone Loss: Implications for Bone Regeneration and Repair. Int J Mol Sci. 2023;24: pubmed publisher |
Polan C, Brenner C, Herten M, Hilken G, Grabellus F, Meyer H, et al. Increased UHMWPE Particle-Induced Osteolysis in Fetuin-A-Deficient Mice. J Funct Biomater. 2023;14: pubmed publisher |
Li Z, Bowers E, Zhu J, Yu H, Hardij J, Bagchi D, et al. Lipolysis of bone marrow adipocytes is required to fuel bone and the marrow niche during energy deficits. elife. 2022;11: pubmed publisher |
Kim J, Yang Y, Xie J, Lee O, Kim J, Hong J, et al. Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes. Cell Death Differ. 2022;: pubmed publisher |
Junqueira J, Louren xe7 o J, da Silva K, Jorgetti V, Vieira R, de Araujo A, et al. Increased bone resorption by long-term cigarette smoke exposure in animal model. Heliyon. 2021;7:e08587 pubmed publisher |
Zhao W, Wiedemann P, Wölfel E, Neven M, Peters S, Imhof T, et al. Decreased Trabecular Bone Mass in Col22a1-Deficient Mice. Cells. 2021;10: pubmed publisher |
Liao N, Koehne T, Tuckermann J, Triviai I, Amling M, David J, et al. Osteoblast-specific inactivation of p53 results in locally increased bone formation. PLoS ONE. 2021;16:e0249894 pubmed publisher |
Lee E, Na W, Kang M, Kim Y, Kim D, Oh H, et al. Hydroxycoumarin Scopoletin Inhibits Bone Loss through Enhancing Induction of Bone Turnover Markers in a Mouse Model of Type 2 Diabetes. Biomedicines. 2021;9: pubmed publisher |
MacLeod R, Meyer M, Xiong J, Cawley K, Liu Y, Onal M, et al. Deletion of a putative promoter-proximal Tnfsf11 regulatory region in mice does not alter bone mass or Tnfsf11 expression in vivo. PLoS ONE. 2021;16:e0250974 pubmed publisher |
Timmen M, Hidding H, G xf6 tte M, Khassawna T, Kronenberg D, Stange R. The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis. Sci Rep. 2020;10:20510 pubmed publisher |
Cawley K, Bustamante Gomez N, Guha A, MacLeod R, Xiong J, Gubrij I, et al. Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption. Cell Rep. 2020;32:108052 pubmed publisher |
Kato S, Tanabe N, Nagao M, Sekino J, Tomita K, Sakai M, et al. Glucose transporter 4 mediates LPS-induced IL-6 production in osteoblasts under high glucose conditions. J Oral Sci. 2020;62:423-426 pubmed publisher |
Koide M, Yamashita T, Murakami K, Uehara S, Nakamura K, Nakamura M, et al. Sclerostin expression in trabecular bone is downregulated by osteoclasts. Sci Rep. 2020;10:13751 pubmed publisher |
Velletri T, Huang Y, Wang Y, Li Q, Hu M, Xie N, et al. Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin. Cell Death Differ. 2021;28:156-169 pubmed publisher |
Sahbani K, Cardozo C, Bauman W, TAWFEEK H. Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide. Physiol Rep. 2019;7:e14225 pubmed publisher |
Heckt T, Brylka L, Neven M, Amling M, Schinke T. Deficiency of sphingosine-1-phosphate receptor 3 does not affect the skeletal phenotype of mice lacking sphingosine-1-phosphate lyase. PLoS ONE. 2019;14:e0219734 pubmed publisher |
Wauquier F, Daneault A, Granel H, Prawitt J, Fabien Soulé V, Berger J, et al. Human Enriched Serum Following Hydrolysed Collagen Absorption Modulates Bone Cell Activity: from Bedside to Bench and Vice Versa. Nutrients. 2019;11: pubmed publisher |
Gao X, Lu A, Tang Y, Schneppendahl J, Liebowitz A, Scibetta A, et al. Influences of donor and host age on human muscle-derived stem cell-mediated bone regeneration. Stem Cell Res Ther. 2018;9:316 pubmed publisher |
Ikebuchi Y, Aoki S, Honma M, Hayashi M, Sugamori Y, Khan M, et al. Coupling of bone resorption and formation by RANKL reverse signalling. Nature. 2018;561:195-200 pubmed publisher |
Zimmerman S, Heard Lipsmeyer M, Dimori M, Thostenson J, Mannen E, O Brien C, et al. Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim). Bone Rep. 2018;9:61-73 pubmed publisher |
Xiong J, Cawley K, Piemontese M, Fujiwara Y, Zhao H, Goellner J, et al. Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss. Nat Commun. 2018;9:2909 pubmed publisher |
Cheung L, Tickner J, Hughes A, Skut P, Howlett M, Foley B, et al. New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment. Leukemia. 2018;32:2326-2338 pubmed publisher |
Lee N, Clarke I, Enriquez R, Nagy V, Penninger J, Baldock P, et al. Central RANK signalling in NPY neurons alters bone mass in male mice. Neuropeptides. 2018;68:75-83 pubmed publisher |
Yang N, Baban B, Isales C, Shi X. Role of glucocorticoid-induced leucine zipper (GILZ) in inflammatory bone loss. PLoS ONE. 2017;12:e0181133 pubmed publisher |
Park O, Kim J, Yang J, Yun C, Han S. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2. J Bone Miner Res. 2017;32:1455-1468 pubmed publisher |
Davis H, Pacheco Costa R, Atkinson E, Brun L, Gortazar A, Harris J, et al. Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging. Aging Cell. 2017;16:551-563 pubmed publisher |
Pezzotti G, McEntire B, Bock R, Boffelli M, Zhu W, Vitale E, et al. Silicon Nitride: A Synthetic Mineral for Vertebrate Biology. Sci Rep. 2016;6:31717 pubmed publisher |
Kassem A, Henning P, Lundberg P, Souza P, Lindholm C, Lerner U. Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts. J Biol Chem. 2015;290:20147-58 pubmed publisher |
Yang Y, Blair H, Shapiro I, Wang B. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. J Biol Chem. 2015;290:16918-28 pubmed publisher |
Maruyama K, Fukasaka M, Uematsu S, Takeuchi O, Kondo T, Saitoh T, et al. 5-Azacytidine-induced protein 2 (AZI2) regulates bone mass by fine-tuning osteoclast survival. J Biol Chem. 2015;290:9377-86 pubmed publisher |
Nollet M, Santucci Darmanin S, Breuil V, Al Sahlanee R, Cros C, Topi M, et al. Autophagy in osteoblasts is involved in mineralization and bone homeostasis. Autophagy. 2014;10:1965-77 pubmed publisher |
Onal M, Bishop K, St John H, Danielson A, Riley E, Piemontese M, et al. A DNA segment spanning the mouse Tnfsf11 transcription unit and its upstream regulatory domain rescues the pleiotropic biologic phenotype of the RANKL null mouse. J Bone Miner Res. 2015;30:855-68 pubmed publisher |
Baek J, Kim J, Cheon Y, Park S, Ahn S, Yoon K, et al. Aconitum pseudo-laeve var. erectum inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis via the c-Fos/nuclear factor of activated T-cells, cytoplasmic 1 signaling pathway and prevents lipopolysaccharide-induced bone. Molecules. 2014;19:11628-44 pubmed publisher |
Teufel S, Grötsch B, Luther J, Derer A, Schinke T, Amling M, et al. Inhibition of bone remodeling in young mice by bisphosphonate displaces the plasma cell niche into the spleen. J Immunol. 2014;193:223-33 pubmed publisher |
Yoo Y, Kwag J, Kim K, Kim C. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. Int J Mol Sci. 2014;15:5874-83 pubmed publisher |
Mosti M, Stunes A, Ericsson M, Pullisaar H, Reseland J, Shabestari M, et al. Effects of the peroxisome proliferator-activated receptor (PPAR)-δ agonist GW501516 on bone and muscle in ovariectomized rats. Endocrinology. 2014;155:2178-89 pubmed publisher |
Ohba T, Cole H, Cates J, Slosky D, Haro H, Ando T, et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. J Bone Miner Res. 2014;29:1431-45 pubmed publisher |
Teramachi J, Zhou H, Subler M, Kitagawa Y, Galson D, Dempster D, et al. Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. J Bone Miner Res. 2014;29:1456-65 pubmed publisher |
Gruenwald K, Castagnola P, Besio R, Dimori M, Chen Y, Akel N, et al. Sc65 is a novel endoplasmic reticulum protein that regulates bone mass homeostasis. J Bone Miner Res. 2014;29:666-75 pubmed publisher |
Gao L, Faibish D, Fredman G, Herrera B, Chiang N, Serhan C, et al. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol. 2013;190:689-94 pubmed publisher |
Buckle C, De Leenheer E, Lawson M, Yong K, Rabin N, Perry M, et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. PLoS ONE. 2012;7:e41127 pubmed publisher |
Onal M, Xiong J, Chen X, Thostenson J, Almeida M, Manolagas S, et al. Receptor activator of nuclear factor ?B ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J Biol Chem. 2012;287:29851-60 pubmed publisher |
Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H. Osteoprotection by semaphorin 3A. Nature. 2012;485:69-74 pubmed publisher |
Ma B, Zhang Q, Wu D, Wang Y, Hu Y, Cheng Y, et al. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. Acta Pharmacol Sin. 2012;33:479-89 pubmed publisher |
Onal M, Galli C, Fu Q, Xiong J, Weinstein R, Manolagas S, et al. The RANKL distal control region is required for the increase in RANKL expression, but not the bone loss, associated with hyperparathyroidism or lactation in adult mice. Mol Endocrinol. 2012;26:341-8 pubmed publisher |
Chao C, Joyce Shaikh B, Grein J, Moshrefi M, Raoufi F, LaFace D, et al. C17 prevents inflammatory arthritis and associated joint destruction in mice. PLoS ONE. 2011;6:e22256 pubmed publisher |
Rufo A, Del Fattore A, Capulli M, Carvello F, De Pasquale L, Ferrari S, et al. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res. 2011;26:1891-903 pubmed publisher |
Mentrup B, Marschall C, Barvencik F, Amling M, Plendl H, Jakob F, et al. Functional characterization of a novel mutation localized in the start codon of the tissue-nonspecific alkaline phosphatase gene. Bone. 2011;48:1401-8 pubmed publisher |
Ho T, Santora K, Chen J, Frankshun A, Bagnell C. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. Bone. 2011;48:1346-53 pubmed publisher |
Sample S, Collins R, Wilson A, Racette M, Behan M, Markel M, et al. Systemic effects of ulna loading in male rats during functional adaptation. J Bone Miner Res. 2010;25:2016-28 pubmed publisher |
Neunaber C, Catala Lehnen P, Beil F, Marshall R, Kanbach V, Baranowsky A, et al. Increased trabecular bone formation in mice lacking the growth factor midkine. J Bone Miner Res. 2010;25:1724-35 pubmed publisher |
Sauer A, Mrak E, Hernandez R, Zacchi E, Cavani F, Casiraghi M, et al. ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. Blood. 2009;114:3216-26 pubmed publisher |
O Connor R, Zayzafoon M, Farach Carson M, Schanen N. Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone. 2009;45:346-56 pubmed publisher |
Wang L, Zhao R, Shi X, Wei T, Halloran B, Clark D, et al. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone. 2009;45:309-20 pubmed publisher |
Pierroz D, Rufo A, Bianchi E, Glatt V, Capulli M, Rucci N, et al. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. J Bone Miner Res. 2009;24:775-84 pubmed publisher |
Valverde P, Zhang J, Fix A, Zhu J, Ma W, Tu Q, et al. Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice. J Bone Miner Res. 2008;23:1775-88 pubmed publisher |
Garlet G, Cardoso C, Campanelli A, Garlet T, Avila Campos M, Cunha F, et al. The essential role of IFN-gamma in the control of lethal Aggregatibacter actinomycetemcomitans infection in mice. Microbes Infect. 2008;10:489-96 pubmed publisher |
Liu J, Xu K, Wen G, Guo H, Li S, Wu X, et al. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice. Bone. 2008;42:950-9 pubmed publisher |
Qiang Y, Chen Y, Stephens O, Brown N, Chen B, Epstein J, et al. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma. Blood. 2008;112:196-207 pubmed publisher |
Morony S, Tintut Y, Zhang Z, Cattley R, Van G, Dwyer D, et al. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice. Circulation. 2008;117:411-20 pubmed publisher |
Niki Y, Takaishi H, Takito J, Miyamoto T, Kosaki N, Matsumoto H, et al. Administration of cyclooxygenase-2 inhibitor reduces joint inflammation but exacerbates osteopenia in IL-1 alpha transgenic mice due to GM-CSF overproduction. J Immunol. 2007;179:639-46 pubmed |
Brechter A, Lerner U. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression. Arthritis Rheum. 2007;56:910-23 pubmed |
Li Y, Toraldo G, Li A, Yang X, Zhang H, Qian W, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood. 2007;109:3839-48 pubmed |
Nakamichi Y, Udagawa N, Kobayashi Y, Nakamura M, Yamamoto Y, Yamashita T, et al. Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts. J Immunol. 2007;178:192-200 pubmed |
Tang C, Hsu T, Lin W, Lai M, Yang R, Hsieh S, et al. Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice. J Biol Chem. 2007;282:2346-54 pubmed |
Sato M, Nakamichi Y, Nakamura M, Sato N, Ninomiya T, Muto A, et al. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro. Bone. 2007;40:293-304 pubmed |
